Nexera updates prospectus for 34K share offering

Rhea-AI Filing Summary

Nexera Technologies Ltd (NEXR) filed a prospectus supplement to update its existing Form F-1 prospectus covering the offering of up to 34,077 Ordinary Shares. The supplement incorporates Nexera’s latest Form 6-K, which includes unaudited condensed consolidated financial statements and management’s discussion and analysis for the six months ended June 30, 2026.

The company’s Ordinary Shares and public warrants trade on the Nasdaq Capital Market under the symbols NEXR and NEXRW. On August 31, 2026, the last reported sale prices were $1.86 per Ordinary Share and $0.0128 per Public Warrant. The supplement also notes that the related promissory notes are not listed on any exchange.

Filing Explained

Beyond updating the F-1 prospectus, the August 31, 2026 Form 6-K is incorporated into the listed Form F-3 and Form S-8 registration statements, making its June 30, 2026 interim financial statements and management discussion part of those filings unless later superseded.

Key Figures

Ordinary Shares registered: 34,077 Ordinary Shares Ordinary Share price: $1.86 Public Warrant price: $0.0128

3 metrics

Ordinary Shares registered 34,077 Ordinary Shares Amount of Ordinary Shares covered by the updated Form F-1 prospectus

Ordinary Share price $1.86 Last reported sale price on August 31, 2026

Public Warrant price $0.0128 Last reported sale price on August 31, 2026

Key Terms

Prospectus supplement, Report of Foreign Private Issuer, Form 6-K, Inline XBRL, +2 more

6 terms

Prospectus supplement regulatory

"This prospectus supplement updates, amends, and supplements the prospectus"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Report of Foreign Private Issuer regulatory

"Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16"

A report of a foreign private issuer is a formal filing that a non‑U.S. company makes to U.S. regulators to share important business, financial, or governance information with American investors. Think of it as a regular update or press packet that keeps investors informed about events that could change a company’s value—like earnings, management changes, contracts, or regulatory developments—so investors can make timely, informed decisions.

Form 6-K regulatory

"information contained in our Report of Foreign Private Issuer on Form 6-K"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

Inline XBRL technical

"Inline XBRL Instance Document"

Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

Form F-3 regulatory

"incorporated by reference into the Company’s Registration Statements on Form F-3"

Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.

Form S-8 regulatory

"Registration Statements on Form S-8"

A Form S-8 is a U.S. Securities and Exchange Commission registration that lets a public company set aside shares for employee benefit plans and stock-based compensation. Think of it as opening a dedicated account that authorizes the company to issue or reserve stock for workers and directors; it matters to investors because it enables share dilution when those awards are granted or exercised and signals how management is compensated and incentivized.

Offering Details

secondary

Offering

Offering Type secondary

FAQ

What does Nexera Technologies Ltd (NEXR) register in this prospectus supplement?

Nexera Technologies Ltd updates its existing Form F-1 prospectus covering an offering of up to 34,077 Ordinary Shares, incorporating new information from a Form 6-K that includes unaudited financial statements and management’s discussion and analysis for the six months ended June 30, 2026.

What new information about NEXR is incorporated by reference in this supplement?

The supplement incorporates a Form 6-K containing Nexera Technologies Ltd’s unaudited condensed consolidated financial statements and management’s discussion and analysis for the six months ended June 30, 2026, now forming part of the company’s various effective registration statements.

What are the recent market prices of NEXR shares and warrants?

On August 31, 2026, Nexera Technologies Ltd’s Ordinary Shares traded at a last reported sale price of $1.86 per share, and its Public Warrants traded at $0.0128 each on the Nasdaq Capital Market.

Are Nexera Technologies Ltd’s promissory notes listed on an exchange?

No. The filing states there is no established market for the promissory notes of Nexera Technologies Ltd and that the company does not intend to apply to list these notes on any securities exchange or other nationally recognized trading system.

Which other registration statements does NEXR’s Form 6-K become part of?

The Form 6-K is incorporated by reference into Nexera Technologies Ltd’s Registration Statements on Form F-3 (multiple file numbers including 333-277188 and others) and on Form S-8 (including 333-269119 and others) from the date of submission, unless later superseded.

Where are NEXR’s risk factors for this offering discussed?

Risk factors for Nexera Technologies Ltd’s securities are described in the section titled “Risk Factors” beginning on page 5 of the base prospectus and in the company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 06:19 AM Accepted by SEC EDGAR 09/01/2026 - 06:16 AM Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(3)
Registration No. 333-288355

PROSPECTUS SUPPLEMENT NO. 5

(To prospectus dated July 24, 2025)

NEXERA TECHNOLOGIES LTD (f\k\a JEFFS’ BRANDS LTD)

Up to 34,077 Ordinary Shares

This prospectus supplement updates, amends, and supplements the prospectus dated July 24, 2025 (the “Prospectus”), which forms a part of our Registration Statement on Form F-1, as amended (Registration No. 333-288355). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.

This prospectus supplement is being filed to update, amend, and supplement the information included in the Prospectus with the information contained in our Report of Foreign Private Issuer on Form 6-K (the “Form 6-K”) furnished to the Securities and Exchange Commission (the “SEC”) on August 31, 2026. Accordingly, we have included the Form 6-K in this prospectus supplement.

This prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement, and is qualified by reference thereto, except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference.

Our Ordinary Shares and warrants issued as part of our initial public offering are listed on the Nasdaq Capital Market under the symbol “NEXR” and “NEXRW” respectively. On August 31, 2026, the last reported sale price of the Ordinary Shares and Public Warrants was $1.86 and $0.0128, respectively. There is no established market for the Promissory Notes and we do not intend to apply to list the Promissory Notes on any securities exchange or other nationally recognized trading system.

AN INVESTMENT IN OUR SECURITIES INVOLVES RISKS. SEE THE SECTION ENTITLED “RISK FACTORS” BEGINNING ON PAGE 5 OF THE PROSPECTUS AND IN OUR ANNUAL REPORT ON FORM 20-F FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025.

Neither the SEC nor any state or other securities commission has approved or disapproved of these securities or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus is September 1, 2026

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934

For the month of August 2026

Commission file number: 001-41482

NEXERA TECHNOLOGIES Ltd

(Translation of registrant’s name into English)

7 Mezada St.
Bnei Brak, Israel 5126112
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒             Form 40-F ☐

CONTENTS

This Report of Foreign Private Issuer on Form 6-K (this “Form 6-K”) consists of Nexera Technologies Ltd’s (the “Company”): (i) Unaudited Condensed Consolidated Financial Statements as of, and for the six months ended, June 30, 2026, which are attached hereto as Exhibit 99.1; and (ii) Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2026, which is attached hereto as Exhibit 99.2.

This Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-277188, File No. 333-262835, File No. 333-283848, File No. 333-283904, File No. 333-285030, File No. 333-287341, File No. 333-293607, File No. 333-295999 and File No. 333-296968) and Registration Statements on Form S-8 (File No. 333-269119, File No. 333-280459, File No. 333-291322 and File No. 333-295195) to be a part thereof from the date on which this Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

1

EXHIBIT INDEX

Exhibit No.
99.1		Nexera Technologies Ltd’s Unaudited Condensed Consolidated Financial Statements as of, and for the six months ended, June 30, 2026.
99.2		Nexera Technologies Ltd’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Six Months Ended June 30, 2026.
101.INS		Inline XBRL Instance Document.
101.SCH		Inline XBRL Taxonomy Extension Schema Document.
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Nexera Technologies Ltd
Date: August 31, 2026	By:	/s/ Ronen Zalayet
		Ronen Zalayet
		Chief Financial Officer

3